Literature DB >> 25945535

Acute retinal necrosis following intravitreal dexamethasone (Ozurdex®) implant.

Murat Kucukevcilioglu1, Mustafa Eren1, Umit Yolcu2, Gungor Sobaci3.   

Abstract

A 52-year-old woman undergoing azathioprine treatment for rheumatoid arthritis developed acute retinal necrosis a month after intravitreal dexamethasone (Ozurdex ®) implantation for posterior uveitis in the left eye. Varicella zoster virus (VZV) DNA was detected in the anterior chamber and vitreous samples on polymerase chain reaction (PCR) analysis. Retinal detachment occurred despite systemic and intravitreal antiviral therapy. Favorable structural and functional outcomes were achieved after retinal surgery with silicone oil. To the authors' knowledge, this is the first reported case of acute retinal necrosis following placement of an Ozurdex® implant. Physicians practicing Ozurdex® implantations should be aware of this unusual but devastating complication. Extra caution and frequent follow-up are required in all immunocompromised patients receiving Ozurdex® implantation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25945535     DOI: 10.5935/0004-2749.20150030

Source DB:  PubMed          Journal:  Arq Bras Oftalmol        ISSN: 0004-2749            Impact factor:   0.872


  6 in total

Review 1.  [Pharmacological treatment strategies and surgical options for uveitis].

Authors:  Justus G Garweg
Journal:  Ophthalmologe       Date:  2019-10       Impact factor: 1.059

2.  Acute retinal necrosis following dexamethasone intravitreal implant (Ozurdex®) administration in an immunocompetent adult with a history of HSV encephalitis: a case report.

Authors:  Zhi-Yong Zhang; Xiu-Yun Liu; Tao Jiang
Journal:  BMC Ophthalmol       Date:  2020-06-22       Impact factor: 2.209

3.  Macular cytomegalovirus retinitis following dexamethasone intravitreal implant combined with phacoemulsification.

Authors:  Mohit Dogra; Vikash Rohilla; Mangat Dogra; Ramandeep Singh
Journal:  Indian J Ophthalmol       Date:  2018-09       Impact factor: 1.848

Review 4.  Intravitreal Dexamethasone Implant as a Sustained Release Drug Delivery Device for the Treatment of Ocular Diseases: A Comprehensive Review of the Literature.

Authors:  Claudio Iovino; Rodolfo Mastropasqua; Marco Lupidi; Daniela Bacherini; Marco Pellegrini; Federico Bernabei; Enrico Borrelli; Riccardo Sacconi; Adriano Carnevali; Rossella D'Aloisio; Alessio Cerquaglia; Lucia Finocchio; Andrea Govetto; Stefano Erba; Giacinto Triolo; Antonio Di Zazzo; Matteo Forlini; Aldo Vagge; Giuseppe Giannaccare
Journal:  Pharmaceutics       Date:  2020-07-26       Impact factor: 6.321

Review 5.  Update on corticosteroids for diabetic macular edema.

Authors:  Stephen G Schwartz; Ingrid U Scott; Michael W Stewart; Harry W Flynn
Journal:  Clin Ophthalmol       Date:  2016-09-08

6.  Comparison of Anatomical and Functional Outcomes of Intravitreal Dexamethasone Implant between Phakic and Pseudophakic Eyes with Diabetic Macular Edema.

Authors:  Havva Kaldırım; Fatma Savur; Ahmet Kırgız; Kürşat Atalay
Journal:  Korean J Ophthalmol       Date:  2020-10-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.